Vanguard Group Inc Adial Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.24 - $0.56 $66,124 - $154,289	-275,517 Reduced 57.53%	203,358 $71,000
Q4 2022 Feb 10, 2023	SELL	$0.2 - $9.25 $27,596 - $1.28 Million	-137,980 Reduced 22.37%	478,875 $105,000
Q3 2022 Nov 14, 2022	BUY	$0.03 - $46.0 $780 - $1.2 Million	26,003 Added 4.4%	616,855 $216,000
Q4 2021 Feb 14, 2022	SELL	$62.25 - $104.5 $223,539 - $375,259	-3,591 Reduced 0.6%	590,852 $1.6 Million
Q3 2021 Nov 12, 2021	BUY	$57.75 - $116.75 $543,312 - $1.1 Million	9,408 Added 1.61%	594,443 $2.55 Million
Q2 2021 Aug 13, 2021	BUY	$50.5 - $78.25 $29.5 Million - $45.8 Million	585,035 New	585,035 $1.49 Million

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.